Martelli N - Search Results

1

HARMONIZING HEALTH TECHNOLOGY ASSESSMENT PRACTICES IN UNIVERSITY HOSPITALS: TO WHAT EXTENT IS THE MINI-HTA MODEL SUITABLE IN THE FRENCH CONTEXT?

Martelli N, Devaux C, van den Brink H, Billaux M, Pineau J, Prognon P, Borget I. Martelli N, et al. Int J Technol Assess Health Care. 2017 Jan;33(2):307-314. doi: 10.1017/S0266462317000393. Epub 2017 Jun 5. Int J Technol Assess Health Care. 2017. PMID: 28580892

2

The application of hazard analysis and critical control points and risk management in the preparation of anti-cancer drugs.

Bonan B, Martelli N, Berhoune M, Maestroni ML, Havard L, Prognon P. Bonan B, et al. Among authors: martelli n. Int J Qual Health Care. 2009 Feb;21(1):44-50. doi: 10.1093/intqhc/mzn052. Epub 2008 Dec 10. Int J Qual Health Care. 2009. PMID: 19073709

3

FabAct®: a decision-making tool for the anticipation of the preparation of anticancer drugs.

Bonan B, Martelli N, Berhoune M, Vidal LA, Sahin E, Prognon P. Bonan B, et al. Among authors: martelli n. J Eval Clin Pract. 2010 Dec;16(6):1129-35. doi: 10.1111/j.1365-2753.2009.01281.x. J Eval Clin Pract. 2010. PMID: 21176003

4

Interest of the preliminary risk analysis method in a central sterile supply department.

Niel-Lainé J, Martelli N, Bonan B, Talon D, Desroches A, Prognon P, Vincent F. Niel-Lainé J, et al. Among authors: martelli n. BMJ Qual Saf. 2011 Aug;20(8):698-703. doi: 10.1136/bmjqs.2010.048074. Epub 2011 Mar 8. BMJ Qual Saf. 2011. PMID: 21385890

5

Use of a risk assessment method to improve the safety of negative pressure wound therapy.

Lelong AS, Martelli N, Bonan B, Prognon P, Pineau J. Lelong AS, et al. Among authors: martelli n. Int Wound J. 2014 Jun;11(3):253-8. doi: 10.1111/j.1742-481X.2012.01081.x. Epub 2012 Aug 30. Int Wound J. 2014. PMID: 22931525 Free PMC article.

6

[Computerized prescription for medical devices: examples, interest and limits].

Galvez D, Martelli N, Dart T, Blanchard D, Prognon P, Pineau J. Galvez D, et al. Among authors: martelli n. Ann Pharm Fr. 2012 Sep;70(5):281-91. doi: 10.1016/j.pharma.2012.06.002. Epub 2012 Jul 12. Ann Pharm Fr. 2012. PMID: 23020919 French.

7

Clinical studies of innovative medical devices: what level of evidence for hospital-based health technology assessment?

Boudard A, Martelli N, Prognon P, Pineau J. Boudard A, et al. Among authors: martelli n. J Eval Clin Pract. 2013 Aug;19(4):697-702. doi: 10.1111/jep.12024. Epub 2013 Mar 19. J Eval Clin Pract. 2013. PMID: 23510375

8

Hospital-based health technology assessment for innovative medical devices in university hospitals and the role of hospital pharmacists: learning from international experience.

Martelli N, Lelong AS, Prognon P, Pineau J. Martelli N, et al. Int J Technol Assess Health Care. 2013 Apr;29(2):185-91. doi: 10.1017/S0266462313000019. Epub 2013 Mar 20. Int J Technol Assess Health Care. 2013. PMID: 23515134 Review.

9

[Hospital-based health technology assessment in France: how to proceed to evaluate innovative medical devices?].

Martelli N, van den Brink H, Denies F, Dervaux B, Germe AF, Prognon P, Pineau J. Martelli N, et al. Ann Pharm Fr. 2014 Jan;72(1):3-14. doi: 10.1016/j.pharma.2013.09.002. Epub 2013 Oct 14. Ann Pharm Fr. 2014. PMID: 24438663 Review. French.

10

Special funding schemes for innovative medical devices in French hospitals: the pros and cons of two different approaches.

Martelli N, van den Brink H. Martelli N, et al. Health Policy. 2014 Jul;117(1):1-5. doi: 10.1016/j.healthpol.2014.04.007. Epub 2014 Apr 21. Health Policy. 2014. PMID: 24794738 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

124 results

Search Page

Filters